A prospective study of Plasmodium falciparum multiplicity of infection and morbidity in Tanzanian children
Henning, L., Schellenberg, D., Smith, T., Henning, D., Alonso, P, Tanner, M., Mshinda, H., Beck, H.-P., and Felger, I. (2004) A prospective study of Plasmodium falciparum multiplicity of infection and morbidity in Tanzanian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98 (1). pp. 687-694.
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
Abstract
Several studies suggest that in individuals with substantial previous exposure to malaria, co-infection with multiple clones of Plasmodium falciparum can protect against subsequent clinical malaria attacks. Other studies, mainly of individuals with little previous exposure, found the converse relationship. To test whether acquisition of such cross-protection tracks the acquisition of clinical immunity in general, 610 Tanzanian children aged 0-6 years were enrolled in a nine-month prospective study of the risk of morbidity in relation to parasitological status and merozoite surface protein 2 genotypes on enrolment. Prevalence of parasitaemia and multiplicity of infection increased with age. In the first year of life, the incidence of clinical malaria was almost three times higher in children with parasites at baseline than in those without. In older children, baseline P. falciparum infections appeared to protect against both parasitaemic and non-parasitaemic fever episodes. In children aged less than three years, baseline multiple infection tended to be associated with higher prospective risk of clinical malaria than single infection while in children aged more than three years the converse was found, but these effects were not statistically significant. These results provide further evidence that relationships between asymptomatic malaria infections and clinical malaria change with cumulative exposure.
Item ID: | 49864 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1878-3503 |
Keywords: | malaria, Plasmodium falciparum, risk factors, genotyping, Tanzania |
Funders: | Swiss National Science Foundation (SNSF), Daniela and Jürgen Westphal Stiftung |
Projects and Grants: | SNSF #31-52967.97 and 31- 52984.97 |
Date Deposited: | 15 Aug 2017 01:44 |
FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111717 Primary Health Care @ 100% |
SEO Codes: | 92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920499 Public Health (excl. Specific Population Health) not elsewhere classified @ 100% |
Downloads: |
Total: 1 |
More Statistics |